Michael Owen is a corporate strategist and applied business economist with Director level expertise gained in Glaxo and Unilever in leading and implementing strategic projects and processes worldwide to drive business growth.
He first used scenarios at Glaxo to help the newly-merged GlaxoWellcome to identify new strategic directions and priorities. He has used his skills since 2001 in consulting projects on EU enlargement, health economics and consumer communications on pharmaceuticals. He has a BSc (Wales) and MA in Economics, is a Member of the Society of Business Economists and has been a frequent speaker at international conferences.
He is the joint author (with Gary Lyon) of: “Direct-to Consumer Communications of Rx Medicines”, Nicholas Hall & Company, 2002.SAMI projects have included using scenarios to future proof CSR policies for a major pharmaceutical company and a stakeholder engagement for the Department of Health. He is a SAMI Fellow.